# A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults

> **NCT07470177** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jemincare** · enrollment: 24 (estimated)

## Conditions studied

- ADPKD (Autosomal Dominant Polycystic Kidney Disease)

## Interventions

- **DRUG:** JMKX003142 tablets
- **DRUG:** JMKX003142 tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07470177
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-27
- **Primary completion:** 2026-05-14
- **Final completion:** 2026-06-23
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470177, "A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07470177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*